Assistance program
Child Development and, Surveillance, Research and Prevention
$1.8 Million committed in FY2018–FY2020
- Agency
- Centers for Disease Control and Prevention, Health and Human Services, Department of
- Assistance
- Cooperative Agreements
- CFDA number
- 93.312
- What it does
- This funding supports State health agencies, universities, and public and private nonprofit organizations in planning, implementing, coordinating, or evaluating programs related to promoting optimal child health and development outcomes of all children by the detection, prevention, and management of factors that may lead to developmental delays or disorders, or increased morbidity, and by promoting optimal developmental practices within families and other systems that interact with youth. Programs may include the following activities: (1)conducting epidemiologic research or surveillance in the area of child development, developmental disabilities, children’ mental health or neurobehavioral disorders such as Attention-Deficit/Hyperactivity Disorder (ADHD) and Tourette syndrome (TS) and related comorbidities; (2)support the improvement of infant and child health and developmental outcomes by establishing resources for both professionals and the public regarding what is known the impact, epidemiology, and interventions for child development, ADHD and TS and related comorbidities;(3) providing a national, State or local platform in the area of child development, developmental disabilities, children’s mental health and neurobehavioral disorders prevention that focuses on improving early identification of and intervention for children with ADHD, TS, and other co-occurring conditions, so children and families can receive the services and support they need;(4) conducting etiologic studies of child development, children’s mental health, and neurobehavioral disorders such as ADHD and TS using population based approaches to enhance existing research or surveillance programs to better address research questions, monitor changes in prevalence and contributing factors, and inform policy and program activities;(5) employing epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with or at risk for developmental delays, developmental disabilities, mental disorders or neurobehavioral disorders; (6) Conduct population based research that describes comorbidities and associated burden of ADHD and TS disseminating data and health information; (7)employing strategies to reduce racial/ethnic disparities in child development and in the identification of ADHD and TS and related comorbid conditions; (8) Fund and support a National Public Health Practice and Resource Center for Attention-Deficit/Hyperactivity Disorder; (9) Fund and Support a National Public Health Practice and Resource Center for Tourette Syndrome;(10) Fund and support projects that promote optional child development and health for all children.